According to the latest Spyglass Study (Trends in remote patient monitoring) that was based on the telephone interviews over 100 health IT thought leaders, the majority (88%) of U.S. healthcare providers surveyed have invested or are considering new investments in RPM solutions to provide quality and cost-effective treatment for chronic disease management.
Meanwhile IDTechEX Report “Technologies for Diabetes Management 2019-2029” forecasts a vast market expansion of technologies for continuous patient monitoring to manage high-risk patients with chronic conditions, including diabetes: the biomedical sensors market will score $43 billion, and revenue from electronic skin patches will reach more than $20 billion by 2029.
In addition to this, Grand View Research recently predicted that the global digital diabetes management market will run to $26,4 billion by 2026, registering a CAGR of 19,4% over the forecast period.
WHY IT MATTERS
The above mentioned statistics just illustrate the key factors that influence new trends in the 2020 health ecosystem and digital innovations in diabetes treatment:
- a growing geriatric population with unhealthy diets is increasingly suffering from diabetes more and more all over the world and requires patients’ self-involvement in the remote treatment of diabetes;
- focus on quality value-based care and home self-monitoring for patients with chronic diseases stimulates healthcare providers rise spending on connected health solutions;
- a wide range of innovations, devoted to remote monitoring, has been developed and is considered continue to grow in mHealth, telehealth, IoT, and artificial intelligence sectors.
WHAT ARE THE LEADING SOLUTIONS FOR DIGITAL DIABETES MANAGEMENT?
Let’s dive into the world of digital diabetes market and see what innovative healthcare solutions have already been developed and released by digital healthcare companies and which should appear in the near future to diminish the growing incidence of diabetes. Here you can see market split between the leading players in the digital diabetes market which manufacture devices and develop software and apps for diabetes management: